be_ixf;ym_202512 d_07; ct_50
NASDAQ:PEP charts & data provided by TradingView

Latest Insights on PEP

2025 Coffee Shortage Will Slam THIS Stock… December 2, 2024 by Matthew Clark Banyan Edge, Economy, Investing With the potential for tariffs and supply chain shortages in 2025, here's a closer look at the market's top coffee stock...
How to Get $94,054 in Tax-Free Income How to Get $94,054 in Tax-Free Income January 22, 2024 by Aaron James Banyan Edge, Income Did you know you could earn $47,025 in tax-free income per year? Here's how your income can stack up in two simple steps.
Should you invest in Novo Nordisk's Ozempic? Should You Invest In “Miracle Drug” Ozempic? November 17, 2023 by Adam O'Dell Banyan Edge, Diversified Investments, Trending From Chealsea Handler to Elon Musk, Novo Nordisk's Ozempic has been hailed a "miracle drug." Is it worth investing in?
New Trading System Zeroes in on the Top 1% of Nasdaq Stocks New Trading System Zeroes in on the Top 1% of Nasdaq Stocks November 10, 2023 by Adam O'Dell Banyan Edge, Stocks, Trading Strategies Nothing will transform your portfolio’s returns quite like a reliable trading system. This one zeroes in on the top 1% in the Nasdaq.
Market calendar Chart of the Day: The Apex Profit Calendar October 30, 2023 by Banyan Edge Team Banyan Edge, Investing, Trading Strategies, U.S. Economy The Apex Profit Calendar is a new AI-based program that takes the guesswork out of investing — by analyzing the “seasonality” of stocks.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

“Loving this. Should have started a long time ago.”

- Jay

“Looks like I have finally found the right person to learn and grow from.”

- James

Share This